Background: Gleason grading system which is used for reporting prostatic adenocarcinoma is an important grading parameter for prognostication and helps in making treatment decisions. Needle biopsy Gleason score correlates well with the final score of majority of radical prostatectomy specimens and even with the serum prostate specific antigen levels. Gleason grading system has evolved from the original scheme summarized by Dr. Donald Gleason in 1970 to a significantly modified system after two major consensus meetings conducted by ISUP in 2005 and 2014. Original scheme and latest modifications of Gleason grading system which still has some major limitations has led to a new 'Contemporary Grade Group system' proposed by 2014 ISUP which in turn adopted by the 2016 WHO classification of tumors of prostate.
Clinical Research: Open Access
Open Access Journal • Gleason pattern 1: It includes tumor with glands having mild variation in size and shape and it is well circumscribed. There is no infiltration into surrounding benign prostatic tissue.
• Gleason pattern 2: It includes glands with moderate variation in size and shape with varying amounts of stroma in between. There may be infiltration of tumor glands into the adjacent benign prostatic tissue.
• Gleason pattern 3: It includes proliferation of small glands with moderate variation in size and shape with variable stroma. Infiltration into the adjacent benign prostatic tissue is usually seen.
• Gleason pattern 4: This typically involves small fused glands, both large and small cribriform glands and poorly formed glands. Infiltration into the adjacent benign prostatic tissue is well seen.
• Gleason pattern 5: In this there is no gland formation and the tumor cells are arranged in sheets and in single infiltrative pattern. Infiltration into adjacent benign prostatic tissue is invariably seen.
We reported both primary and secondary pattern and added together to get a Gleason score. Gleason score was provided separately for individual cores. Highest score was mentioned in the final impression.
Reporting the Contemporary Group grading system-CGGS [4]
CGGS is studied with reference to existing Gleason system for proper understanding and categorization of morphological patterns.
• Grade Group 1: This includes individual discrete well formed glands. This correlates with GS score of 3+3.
• Grade group 2: It includes predominantly well formed glands with a smaller component of poorly formed / fused / cribriform glands. This correlates with GS score of 3+4.
• Grade group 3: It includes predominantly poorly formed/ fused/cribriform glands with smaller component of well formed glands. This correlates with GS score of 4+3.
• Grade group 4: It includes only the poorly formed / fused/cribriform glands. This correlates with GS score 4+4/3+5/5+3. It can also include predominantly well formed glands with a smaller component of lacking glands i.e., GS score of 3+5. It can also include predominantly loss of gland formation and a smaller component of well formed glands i.e., GS score of 5+3.
Introduction
Gleason grading system which is used for reporting prostatic adenocarcinoma is an important grading parameter for prognostication and helps in making treatment decisions. Ultrasound guided prostatic core biopsy Gleason score correlates well with the final score of majority of radical prostatectomy specimens and even with the serum prostate specific antigen (PSA) levels [1] . The Gleason grading system was proposed by Dr Donald Gleason based on a study in 1959 [2] . Gleason grading system defined five histological patterns or grades which includes most well differentiated at one end and the least differentiated at the other. The World Health organization (WHO) has included Gleason grading system in 2004 as a part of prostate cancer classification. This system also forms the base for many other cancer staging systems like AJCC/UICC. However many changes have been proposed since its inception to update the original Gleason system. Most important step in this direction is the International Society of Urologic Pathology (ISUP) consensus published in 2005. This meeting brought about a good number of required changes in the existing Gleason system bases on consensus from more than 70 urologic pathologists. Another important meeting was held at Chicago in 2014. It included not only pathologists but also other specialty doctors from urology and oncology who are involved in treatment of patients with prostatic adenocarcinoma [3] . Although many changes were made to the original Gleason system in 2005 and in 2014 meetings, there still exist a lot of shortcomings in its current use for prostatic carcinoma reporting either in prostatic core biopsies or the radical prostatectomy specimens. To address the same, a new grading system was proposed by the group from John Hopkins's hospital. This new prostatic grading system has benefits like more accurate grade stratification than the Gleason grading system [4] .
Materials and Methods
Prostate core biopsies from Aug 2016 to July 2017 received in the department of pathology, Institute of NephroUrology, Bangalore, Karnataka, India were included. Sextant biopsies (6 cores from each case representing left upper, middle and lower lobe and right upper, middle and lower lobe) were received in 10% formalin. All the cores were embedded and sections were cut at 3-5 microns. Hematoxylin and Eosin (H & E) staining was done and examined by pathologists. Individual cores from each case were reported independently following both Gleason grading system (GS) as well as Contemporary Grade grouping system (CGGS).
Reporting of Gleason grading system-GS
GS is based on glandular architecture/histological pattern. GS defines five histological patterns with most well differentiated glands at one end of the spectrum and the least differentiated at the other end. The primary pattern which is most common pattern and the secondary pattern which is the next most prevalent pattern are noted and added together to get a final Gleason score.
Discussion
GS till date is very important predictor of prognosis in prostatic adenocarcinoma and helps surgeons and oncologists to decide the clinical management. GS differ from other tumor classification that it is based on glandular pattern or the architecture rather than tumor cell morphology and it is used worldwide [5] . Although 2005 and 2014 ISUP grading consensus conferences have made significant changes for the original GS [6] [7] [8] [9] , still there are some major limitations. The Most important problems with the current Gleason system is,
• Scores 2 to 5 are no longer used for reporting now since minimum score of 6 is the lowest possible score. Previously reported score of 6 are now graded as 7 after the consensus meeting, thus making GS score 6 cancers having a better prognosis than previous score 6 cancers.
• For any research studies or for prognostic or therapeutic purposes Gleason scores are usually divided into 3 groups i.e., GS 6, 7 and 8-10. For cases with GS score of 7, which can be as a result of 4+3 or 3+4, both have a different prognosis i.e., GS 3+4=7 having better prognosis than 4+3=7.
• In routine histopathology reporting of prostatic adenocarcinomas, the lowest possible score is 6, although the theoretical possible score is 2. So it will be assumed by patient part that the diagnosed cancer with GS score of 6 is almost crossing the middle of the cancer scale 2-10. This CGGS was reported for individual cores with highest grade mentioned in the final impression.
We mentioned both the GS score and CGGS in the reports. Other histopathological parameters which are not included in both the grading system like perineural invasion (PNI), lymphovascular emboli (LVE) were mentioned and included in the histopathology report.
Associated features like atypical small acinar cell proliferation (ASAP) and high grade prostatic intraepithelial neoplasia (HGPIN) were noted and mentioned in the histopathology report when found in particular cases (Figure 1-4) .
Results
We received a total of 46 core biopsy samples during the study period. Out of 46, Seventeen were reported as prostatic adenocarcinoma, 2 were ASAP, 2 were HGPIN and rest were benign prostatic tissue. Clinical Research: Open Access Open Access Journal leads to the fear and psychological stress that the cancer is serious and the treatment is mandatory, whereas majority of the GS score 6 cancers behave indolently without the much needed ancillary therapy apart from surgery.
To come up with the above shortcomings new CGGS is proposed. This system is based on the data from the John Hopkins hospital which included > 20,000 patients treated by surgery and > 5000 patients treated by radiotherapy. This was validated in a multi centric and multi institutional study. This new CGGS includes only five distinct grade group based on modified Gleason score groups as mentioned before in the study format. This new grading system has been accepted and included as a part of prostatic cancer classification by the World Health Organization in 2016. This study has taken biochemical recurrence as the endpoint for prognostication of different grades [4] . This reporting system can be further optimized by incorporating the additional histological factors like reactive stroma into routine assessment [10] . In our observational study, the study period is 1 year and there was no correlation with radical prostatectomies. For prognostic purposes cancer recurrence has to be followed up over long periods with biochemical recurrence which is not done in our study. There is limited number of pathological research studies comparing the traditional vs contemporary grade grouping system.
Conclusion
Gleason system for prostatic carcinoma is an important and universally used grading parameter for prognostication and classifying patients based on glandular architecture. It has stood the test of time for more than 4-5 decades. Although modification has been done over the time by consensus conferences, it has got some major limitations. To overcome these limitations, a new contemporary Grade grouping system has been proposed recently. The new Contemporary grading system has simplified 5 grades with lowest possible grade of 1 with more accurate grade stratification. The new grading system has been accepted and included in prostate cancer classification by world health organization in 2016.
As a pathologist's point of view, reporting of prostate core biopsies based on glandular architecture at low power examination gives better information about the grades. Since we are accustomed to the traditional GS, we should report the score and also simultaneously concur with the grade of CGGS. It may be difficult initially to follow the CGGS without the scoring of GS. We recommend reporting by following contemporary grade grouping system (CGGS) along with the traditional Gleason system (GS) till it becomes widely accepted and practiced. We also feel perineural invasion, lymphovascular emboli and any associated HGPIN although not included in any of the grading systems, and they should be mentioned in the final impression so that it may help with the treating urologists in making treatment decisions.
